opnMe News

Let´s live innovation. Want to know the latest news and trends? Read more

Subscribe to our newsletter to stay up to date with latest developments

Latest news

20 April 2018

We have now launched an updated and greatly expanded version of BI Miner on opnMe. Its mission is to save time and effort when performing online scientific queries as it combines several search modes into one single tool. The search engine works very intuitively and is pretty much self-explainable.

12 April 2018

Our β2 adrenergic receptor (β2AR ) agonist BI-167107 was used to support crystallization of active state β2AR and β2AR-G-protein complexes by Prof. Brian K. Kobilka as highlighted in his Nobel Prize Lecture in 2012 (The Structural Basis of G-Protein-Coupled Receptor Signaling (2012 Nobel Prize for Chemistry)). The compound could potentially be employed for the crystallization of other beta receptors.

19 March 2018

Boehringer Ingelheim’s well-characterized, potent and selective BRD9 inhibitor BI-9564 and the dual BRD7/BRD9 inhibitor BI-7273 are now available on opnMe.com. Both were developed in collaboration with the Structural Genomics Consortium (SGC).

21 February 2018

(“A problem shared”, Issue #218 / Feb 2018) features an interview with Adrian Carter, Corporate Vice President and Global Head Discovery Research Coordination, Boehringer Ingelheim. He talks about the strengths and merits of open innovation and crowdsourcing in the context of the pharmaceutical industry.